This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk02: Greetings and welcome to TipTree, Inc. Second Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Sandra Bell, Chief Financial Officer.
spk00: Good morning. and welcome to our second quarter 2021 earnings call. We are joined today by our executive chairman, Michael Barnes, and CEO, Jonathan Alani. You can find the slides that accompany this review on our investor relations website. Please note that some of our comments today will contain forward-looking statements based on our current view of our business. and actual future results may differ materially. Please see our most recent SEC filings, which identify the principal risks and uncertainties that could affect future performance. In addition, we will discuss certain adjusted or non-GAAP financial measures, which are described in more detail in this morning's presentation. Reconciliations of non-GAAP financial measures and other associated disclosures are contained in our SEC filings, the appendix to our presentation, and posted on our website. With that, I will turn the call over to Michael.
spk05: Thanks, Sandra. Good morning, everyone. Our second quarter performance was a continuation of the positive trends we have experienced over the past year with all businesses contributing. First half revenues of $594 million and net income of $36.6 million were both up substantially from 2020, driven by the particularly strong performance of Ortegra, our specialty insurance business, Reliance, our mortgage business, and gains on investment holdings across the company. After removing the impact of investment gains and losses, first half revenue growth was 35% and adjusted net income of $26 million increased 51% from the prior year, both great results. Our insurance business, the Fortegra Group, continues to deliver on its growth objectives while maintaining focus on underwriting discipline that has contributed to consistent results over the past several years. In the quarter, the team crossed a significant milestone with over $2 billion in trailing 12-month gross written premiums and premium equivalents. That represents an exceptional 23.8% annualized growth rate since 2017. Year-to-date written premiums and equivalents of nearly 1.1 billion were up 51% versus the prior year, driven by robust organic growth across all lines of business. Adjusted net income for the first half was $26.9 million, up 52%, driven by revenue growth and an improved combined ratio. The adjusted return on average equity was 18.3%, up 550 basis points from the first half of 2020. Once again, Fortegra's results demonstrate the attractiveness of combining a market-leading specialty insurer with a capital-light warranty business. As we look forward, we expect this performance to continue, led by a growing top line and consistent combined ratio. Switching to Tiptree Capital, our three primary investments in mortgage origination, senior housing, and maritime transportation all generated positive net income for the quarter, and it is worth noting that Tiptree Capital, on a standalone basis, now has over 195 million of book value. Adjusted net income within Tiptree Capital was 14 million for the first half, up substantially from the prior year, driven by strong performance in our mortgage and shipping operations. The mortgage business had another excellent quarter, as the rate environment and home price appreciation continued to be tailwinds. Volumes were up 7% year over year, while gain on sale margins remain healthy compared to long-term historical averages. We believe the business can continue to deliver strong returns, particularly given the low interest rate environment and steady demand for cash-out refinancings across the country. In addition, we have been adding to our mortgage servicing asset, which serves as a source for higher margin recapture volume and is a potential hedge in a rising rate environment. Our shipping business also generated positive results for the first half based on continuing favorable market conditions, particularly in the dry bulk sector. Overall, we are very pleased with the first half performance and believe TipTree is well positioned for the second half of 2021 and going forward. With that, I'll pass it to Sandra, who will take you through the financial results in more detail.
spk00: Thank you, Michael. On page three of the presentation, we highlight TipTree's key financial metrics for the second quarter 2021 compared to the prior year period. Net income for the quarter was $8 million, driven by continued growth in the insurance business and positive performance in our mortgage and shipping operations. Excluding investment gains and losses, revenues were up 45% for the quarter, driven by organic growth in insurance operations, strong mortgage volumes and margins, and increases in dry bulk charter rates. Adjusted net income for the quarter was $13.1 million, representing a 13 percent annualized adjusted return on average equity. These strong operating results were driven by the growth in revenues as well as the consistent combined ratio at Fortegra. Book value per share of $11.59 increased by 17.9% versus the prior year. Compared to the first quarter, 2021, book value per share declined by 4 cents, primarily driven by legal and accounting fees associated with the preparation of the Fortegra IPO, the exchange of certain dilutive securities, and our second quarter dividend, the combination of which offset the positive earnings for the quarter. Turning to page four, we highlight our capital allocated between Fortegra and Tiptree Capital, along with their respective returns to assist investors in understanding Tiptree's intrinsic value. Over the last 12 months, Adjusted return on average equity improved to 16%, an increase from 9.5% in the prior year. For Tegra's adjusted return on average equity for the latest 12-month period improved to 18.4% from 13.7% in 2020, driven by organic growth in the capital light warranty businesses and commercial and personal lines programs. all while maintaining a combined ratio in the low 90s. Our mortgage business generated outsized returns on capital, driven by improvement in both volumes and margins, which have benefited from a strong housing market, both of which were partially offset by increased interest expense, resulting from our upsized corporate borrowing facility completed in early 2020. Before diving deeper into Fortegra's results on page five, I would like to take a moment to remind everyone of the key characteristics of its business model that support such consistent profitability and the opportunity for future revenue and earnings growth. Fortegra is a specialty insurer that focuses on underwriting small premium per risk insurance, that is, underwriting programs that are more frequency exposed but do not present significant aggregation or catastrophic loss exposures. From a competitive point of view, large standard insurers who prefer to individually underwrite each transaction and touch every claim avoid small premium per risk insurance because the infrastructure and personnel costs required preclude them from underwriting profitably. Fortegra uses proprietary technology to overcome this challenge. Both our U.S. insurance and U.S. and European warranty offerings also generate a significant component of fee-based earnings, which contribute to the stable profitability. In addition, Fortegra's warranty product offerings benefit from being capital light as a result of a combination of unregulated earnings and predictable loss ratios. As Michael mentioned, we continue to see strong momentum in Fortegra's top line results. For the second quarter of 2021, premiums and equivalents increased 79% year over year, driven by growth in all lines of business, including admitted, excess and surplus, and warranty lines. As a reminder, particularly with respect to longer duration warranty contracts, Much of the increase in this metric ends up on the balance sheet as GAAP recognizes the revenue over the life of the contracts. Deferred revenues and unearned premiums, which represent this future earnings potential, stood at $1.4 billion, up 40% year-over-year. For the quarter, underwriting and fee margin increased to $57 million, up $17 million, or 44%. and the combined ratio held stable at 92 percent. On page seven, we highlight the KPI trends over the past three years. Gross written premiums and premium equivalents have increased 37 percent over this period, with a 26 percent organic growth rate. Importantly, the combined ratio has consistently improved. moving from 93.3% in the 2019 period to 91.8% in the 2021 period. Ortega's business model maintains strong economic alignment with its distribution network, which is important in delivering consistency in the combined ratio. Several of the underwritten programs have variable retrospective commission structures, meaning if a book of business is profitable, we will share that underwriting profitability with our agents. If it is not profitable, we reduce their commission and the economics are rationalized. We evaluate the performance of the business using adjusted net income, which removes realized and unrealized gains and losses, purchase accounting amortization, stock-based compensation, and non-recurring items. This metric has improved from 13.4 million in the first half of 2019 to 26.9 million in the first half of 2021, which has improved the adjusted return on equity from 10% to 18% over the respective periods. Turning to the next page, we believe the hallmarks of Fortegra's business model underlie the opportunity for consistent growth and underwriting profitability, combining underwriting revenue and unregulated fee income, which leads to more predictable cash flows and enhanced returns. This plan is executed across three key areas. The first two are admitted programs and surplus lines programs, both in U.S. insurance. And the third is balance sheet light programs, which is warranty solutions. We believe it is the combination of these three and the complementary nature of these diverse revenue streams that allows Fortegra to grow and grow profitably regardless of where pricing is in the P&C market cycle. On page nine, we highlighted the key growth considerations. First, Fortegra has a high persistency rate with its agents. which generates a large volume of recurring revenue. Over the past five years, revenues have increased at a 16 percent annual growth rate, or 12 percent organically. Second, we write multi-year contracts that generate significant upfront cash flow to the balance sheet and provides greater visibility into the upcoming year's revenue base. Third, new programs are added for both existing agents and from new agents. Our technology gives us the ability to identify opportunities to expand participation by our agents' clients in the programs we offer, to underwrite new programs profitably given the amount of data available to us to analyze the risks, and to scale volumes efficiently when we add new agent relationships. Our recently announced expanded partnerships with Badcock & Moore in the U.S. and MotorPoint in the U.K. are great examples of how we can add new business. Lastly, this business continues to expand geographically. We are very pleased with the opportunities in Europe where we can leverage our broad experience in the warranty space. We have a strong presence in Central and Eastern Europe and are growing into Western Europe and even the Pacific Rim. As you can see by the size of these addressable markets, we believe Fortegra has the opportunity to continue to expand its volumes and agent relationships without compromising underwriting profitability. Turning to the insurance investment portfolio on page 10, total investments and cash and cash equivalents ended the quarter at $815 million. up 36% year-over-year in line with the underlying premium growth. We invest nearly 80% of the portfolio in high credit quality and liquid securities with an average rating of AA. First half net investment income was $6 million, up slightly as the overall portfolio increased in line with premiums. Net realized and unrealized gains were $12.5 million for the first half, driven by unrealized gains on equities. The capital and liquidity position remained strong at Fortegra, with $288 million of stockholders' equity and a debt capacity of $200 million, both of which put the business in a solid position for future growth. On page 12, we present the results of Tiptree Capital. which as Michael mentioned earlier, consists of our Invesc shares, shipping, and mortgage operations. For the first half, pre-tax income is driven by unrealized gains on our investment in Invesc, which is marked to market based on its share price, in addition to strong volumes and margins in our mortgage business. First half 2021, adjusted net income in Tiptree Capital increased to $14.2 million, primarily driven by improvement in mortgage volumes and margins and dry bulk charter rates. As Michael mentioned, our mortgage business has benefited from several tailwinds, including higher refinance volumes supported by both low rates and rising home prices. And lastly, we've been able to retain mortgage servicing rights at relatively low valuations, providing opportunity for value appreciation in the future rising interest rate environments. As of June 30th, 2021, the fair value of the MSR asset was $23 million. Now we will turn the call back to Michael to conclude our prepared remarks.
spk05: Thanks, Sandra. As I mentioned in my earlier remarks, we are pleased with the first-half performance of our businesses. Over the past five years, Fortegra has increased its top-line production at a 24% growth rate while delivering a best in class combined ratio of just under 92%. We believe these trends will continue and place a premium value on the consistency that the business generates year in, year out. The earning strength of our mortgage business in a low interest rate environment serves as a great example of the embedded upside optionality and diversity of our capital allocation. Within shipping, the demand-supply imbalance in the bulker and tanker market continues to play out and has benefited our business as global economies reopen. We continue to believe that Tiptree's overall intrinsic value has increased significantly and is materially greater than our current stock price would suggest. As we look forward, we believe Tiptree is well positioned to continue executing on our long-term growth objectives, With that, we will open the line for questions.
spk02: Ladies and gentlemen, we will now be conducting a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad, and a confirmation tone will indicate your line is in the question queue. You may press star 2 if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment, please, while we pull for questions. Our first question is from Jeff Bronchick with Cove Street Capital. Please proceed.
spk04: Good morning, everybody. Hey, folks. Just two quick questions. First on just the press release, and I know there's acquisitions, it's insurance accounting, it's a lot of things moving forward, but just As you list, you know, as a 630 print versus year end of the equity holdings of 200 million versus 120, and then assets held for sale went down. Is there, could you put a little color on that movement?
spk05: Sure, Jeff. I'm happy to, and thanks for the question. And good to speak to you again. So, yeah, I guess the value of our equity holdings is going to fluctuate on two basis. One is if it goes down in price, and two is if we sell down the position. We're actively managing whatever equity positions we hold, and frankly, we've had stability in our invest holdings over the last few quarters, so that has remained relatively stable, and we continue to work with management and invest to try to optimize value for that investment. In our insurance company float, we had a very nice reopening trade on prioritizing transportation and oil and gas sectors. As we realized significant value in those trades, we've taken steps to reduce that, as well as some public company position we had in the shipping sector. So we've effectively just taken some profits there. And I'm sorry, Sandra, I apologize, Sandra. If you have anything you want to add to that, please feel free to add.
spk00: Yeah, Jeff, one anomaly, which if you get into our footnotes a little bit more clearly, is we have a fixed income ETF position that supports our business in Europe. And that was about 93, 94 million of that number as of the end of the second quarter. And as Europe has grown, that ETF has also grown as a piece of the equities. And it gets accounted for as equities and mark-to-market like equities, even though it's a fixed income ETF. So that was a bit of the anomaly that happened from year end to the end of the second quarter.
spk04: And so, again, it would be fair to say that Invesk is, you know, an asset held for sale, you know, similar to what you've spoken about in the past, long-run value maximization, but, you know, not a core holding. That would be – continue to be correct, right? I think that's fair to say. Got it. And, I mean, God, I rarely compliment management on a call, but the shipping – purchase was astute. But is that, again, something that was bought to be sold? Or, you know, are we going to be talking about your shipping position in five years? How do you view that?
spk05: Yeah, so we started looking at the shipping business, I'd say, probably almost five years ago. It's a sector that allows one to look at a lot of different industry segments that feed into the shipping sector. I'll say that in investing in shipping, we took a very long-term view that starts with certainly the asset play, first with dry bulk, second with tankers. We've added a small position of a small shipping vessel in the U.S. more recently. And we also, as part of the transaction that we began with, also have a partial ownership interest in a paint business that supplies paint for ships. So we look at this as a way of participating in a broad range of diversified businesses. You start with the asset play, but the long-term objective is also to build out a presence in management as well as to, again, be in the business to take advantage of opportunities. I'd say that we evaluate that business regularly. We did a full top to bottom review very recently, and I'll say that business is on path to our expectations of not exceeding them. To your point, as we entered into the asset play, although we were hit with the coronavirus and had the peculiar benefit to the tanker sector during 2020, Now, through the reopening of economies, we're seeing the benefit in the dry bulk side, which is significant. We hold our ships at purchase plus minus depreciation, not reflecting where they could be sold in the market, and certainly in the dry bulk, I would give my own view that I think that could be higher in the current market, and we will opportunistically take advantage of markets to decide whether to allocate more if we feel that a market is undervalued in a particular shipping sector or to downsize. However, I would say to achieve our objectives in building a management presence in the ships that we own, as well as those that we may take on in JVs with third parties, maintaining ownership and chips, at least through the beginning stages of building up management, is essential. So we start with the asset. I think that our premise as to where we were in the cycle, as well as what's been played out more recently since coronavirus was correct, and we benefited from some of the ups and downs of these last two years, as well as the building out of our management company, I think is right on track. But I'll say that long-term, we will selectively decide whether to allocate more or not. But so far, we are right on path to what we expected.
spk04: And my last general question would be, so what can you say, again, post-Portegra IPO attempt? Is that a continually on a plate subject to opportunities and market conditions? Is this you know, hey, didn't work for reasons previously noted, it's shelved for 2021, we'll review it later, or what could you say about that process?
spk05: Sure, and thanks for the question, Jeff. No, I'm happy to speak about it. We started down the path looking at an IPO for Frategra actually almost a year ago, and knowing that that would ultimately come to an IPO potential in April of this year. The process, frankly, went relatively smoothly and we had set out a number of objectives that we wanted to achieve in taking Fortegra public. One of the primary objectives was to create a platform for Fortegra to continue its growth in the future and to have a platform in the public markets that we believed would allow it to access capital more efficiently then TipTree could continue to provide it. We felt that as a specialty insurer, particularly in a capital-like business like Warranty, it was a very attractive standalone platform with what we felt would be a very good valuation that would allow it to continue to grow, raising its own capital independent of TipTree. Aside from that, and by the way, I think we could have taken Fortegra public. We decided to pull the IPO based upon market conditions at that time and based upon the question as to whether we were truly achieving all of our objectives from the beginning. Now that we pulled the IPO, I will tell you that it is very much something that we are continuing to consider. We believe that we can continue to meet our growth targets without significant capital coming in, although we will again consider what capital is needed for either acquisitions or growth as we go forward and whether we want to raise or bring in capital for that. But right now, as I think communicated previously, we believe for Tegra can continue to meet its growth objectives being part of TipTree for the time being. However, The objectives that we had set out a year ago, I think, remain. And so we are focused on, at some point, whether it would be optimal to revisit the IPO market again. And I would say that that is very much in our thinking. Thanks. Thanks, folks. Sure.
spk02: Our next question is from Walter Shanker with Maz Partners. Please proceed.
spk01: Hi, Michael. Hi, Sandra. Hi, Walter. This is sort of a piling on question. Sure. But I've known the company for about, I'm guessing, five years. I met them at a conference, Sandra, at a conference a number of years ago. If one looks at 10 years, five years, and I'm very long-term, my biggest position I own for 15 years, the stock has sold under book value recently. I suspect virtually throughout the whole period. There was a brief period with the Fortegra IPO where it sold higher, but even today it is still close to 20%, 15%, $10, $11.90, under book value. The concept of a portfolio of assets, and I listened on the shipping, and I listened to creating a management company as opposed to just fortuitously buying an asset at good timing and hopefully selling it, seems to imply a longer and stronger commitment to shipping is not well received in the marketplace, not for a month, not for six months, for five or ten years. How do you look at, and this is more to Michael than anyone else, you're the largest shareholder, so you have the biggest economic interest, but I'm a shareholder. How do you look at your and the board's commitment, and I know you can't talk for the whole board, and I know you've bought more stock yourself to realizing or trying to create within a reasonable timeframe. And I'll call you five and 10 years, a reasonable timeframe, historically value, because I am convinced that you're convinced too, by the way, everyone's convinced that if you were to just sell off the non for Tegra assets, mortgage isn't going to get a lot better than it is today. Um, the stock would be much higher. You'd have a clean insurance company, probably. I'm making up a number, but at $20 a share because of the $7 you get for selling off the other assets. We've had this discussion. I'm doing it again in a public forum. Just give me your view of creating shareholder value in a reasonable timeframe. I happen to be in my 70s, so my timeframe is no longer another 10 years.
spk05: I'm only one shareholder, though. Thanks for the question, Walter. You're not alone in that question, I'll say, and I'm happy to address it. Look, we, from our inception 14 years ago, we created TipTree to be in a position with permanent capital to allocate to the highest yielding and most interesting and attractive opportunities. We're small, and that is some constraint. However, We are in a position to find, I think, unique opportunities given our background, our deep experience, particularly across financial services sector and other hard asset investments. And our priority, as I've said many times, has been to look for great management, cash-flowing businesses, scalable, and I've spoken about this often, with an embedded optionality. And you've seen a few of our business, I think, start to untap that. The idea of getting paid while holding an option is our objective. And I think all of our investments reflect that, and some of which we've now seen really come into the money in that regard. Our mortgage business, one example. We have always, as an investment either matures or as others value it greater than we may, we have sold assets and then reallocated the capital. And there's nothing that is more transparent than cash. And so you have seen us over the years occasionally return to cash and sell investments. And again, one of the things I like about our business right now is that they are all cash flow driven businesses. They're all cash businesses, which as we perform, we're accumulating more cash. And I like that. So that is going to continue to be our objective. Now, to your point, one of the things that I've people may even be getting tired of me saying is our stock price doesn't reflect our intrinsic value. And it doesn't. And I think as evidence of that, the Protegra IPO, which, you know, as I said, if we really chose to, we probably could have forced through. And I think we made the right decision not to. And we will revisit that, I believe. But you look at the intrinsic value of our pieces, and they are materially higher than where our stock price trades And, again, creating transparency to that value, either through an IPO or Fortegra or through the sale of certain assets as they mature, you should expect to see us do that as we go forward. Now, that being said, your question is one of the most common questions I get asked, When will you bridge the gap between, how will you bridge the gap between where you're trading and intrinsic? We see the intrinsic. How do we get there? And two, when will we get there? And in fact, you may have seen as part of our filings, we did just put in place with our board approval a new incentive structure whose purpose is to prioritize increasing share price materially and particularly to achieve significant growth in share price with a time constraint placed on different levels at which are targeted. So we recently created an incentive structure for management to prioritize this, and so creating a timeline to try to reflect that value, management is very incentivized to do that. And so, you know, I would draw your attention to that filing, and I'm happy to discuss it offline if you want to discuss further.
spk01: Okay. Thanks, Michael.
spk05: Sure.
spk02: Thank you. As a reminder, if you would like to ask a question, please press star 1 on your telephone keypad, and a confirmation tone will indicate your line is in the queue. Our next question is from Joe Solano, a private investor. Please proceed.
spk03: Hey, guys. Can you hear me?
spk05: Hi, Joe. I hear you.
spk03: Good. This is almost an ironic question for a stock that trades at six times P.E., but your growth is almost too good to be, you know, To be imagined. And again, I realize the irony there, you know, for a stock that trades at just a subpar multiple. But can you please help explain the very impressive growth in Fortebra, right? Unearned premiums and deferred revenue up something like 40% year over year is, again, for any company, even companies trading at 20 times earnings, that's stellar. And can you just kind of flesh out how you guys are producing that and doing it in a reasonable and profitable fashion?
spk05: Sure. I'd be happy to, and I'll ask Sandra to certainly add to my answer as well. Number one, we've got great management. And I'd say that across all of our businesses, just not for Tegra. We've got great management. And in certain of our businesses, for Tegra particularly, there are certain elements of the economies today that are certainly tailwinds are benefiting us. In the case of Fortegra, I'll say as it relates to our mortgage business, that's definitely true. So I think that as we see continued low rates and on price appreciation, we should expect to see continued positive performance in that. And we happen to be building out our servicing book as well that will serve as a nice hedge and also allows us to recapture high margin business in refinancings. In Fortegra, Not only do we have great management, we've also made some very good acquisitions over the last number of years, particularly in the warranty space and the auto warranty space. As I said, there are certain tailwinds in the economy, particularly as it relates to secondhand autos and the continuation of warranty for those that choose to keep their cars as opposed to trade up. That probably certainly have added some tailwinds. But to be frank, it's a sector that is capital light. that we have made some key acquisitions over the last few years, adding to Protegra's overall business. And with management that we have, I think they've done a fantastic job just continuing to grow those platforms. But Sandra, I don't know if you want to go a little deeper or if you have anything you want to add to that.
spk00: Yeah, I think, Joe, you asked really two components of the question, which how do you support growth, but also how do you support it profitably? And I think we covered both of those at a high level in the prepared remarks. And if you look at page nine of the investor presentation, I think we covered three components in this. First and foremost, the addressable markets in the areas where the growth are massive relative to Fortegra's current position. So it allows us to be selective while still growing. And we really grow in three ways. The obvious one is we add new programs and agents. But even within our agents, because of our technology and the data that we have, because we have very consistent relationships with those agents, We do that because we can help expand their penetration among their client base by providing them additional data. And also because of the data we have and the nature of the programs that we underwrite is we can continue to grow their business profitably because we understand the risks really well. So those are the three reasons why we can support the growth. But again, I'll just, if you look at historically, and we lay these metrics out on another page in the presentation, on page seven, we have a very consistent combined ratio. It varies very little, maybe one to two percentage points since we have owned them and over history. And I think that is really because of the nature of the business model, the high fee component, the technology-enabled platform, and the relationship between frequency exposure versus severity exposure and the predictability of the underlying claims. So I think those are really the key points that allow us to support the kind of profitable growth on a consistent basis.
spk05: And Joe, I think the last thing I'll say is on a consistent basis, I think you should expect that at the moment we see nothing that would inhibit or constrain Protegra from continuing to grow as it has. So we're very excited about that business.
spk03: And I know it's impossible to totally answer this question in detail, but you know, maybe you can offer a sense of how much of your growth is taking market share. For example, I suspect that the entire industry, you know, the lines that you guys play in are not growing in aggregate, you know, 31%, I'm sorry, 40% year over year. And by the way, I think most of that is organic. I know you guys made, correct me if I'm wrong, So if the entire space isn't growing that much, which again, my guess would be it's not, you guys are taking share. And so is there a way to kind of guess ballpark-ish how much of this is you guys taking share? How much is it the whole market growing? And if you're taking share, how?
spk05: So Joe, good question. And I'll say that you're correct, that we certainly have been primarily growing that business organically from the acquisitions that we made. That being said, it is a large market where we're still a small player. And I think taking our market share is definitely part of the plan. And again, that goes to management, our experience, again, understanding the risks, as Henry said. So I would expect that you'll see our wanting and out there taking additional market share as we see opportunity. Sandra, do you want to add anything?
spk00: No, Michael, I think that's fair.
spk05: Okay.
spk03: Okay, and let me just, if I may ask one more question, I think mainly for Michael, but in valuing Fortegra and in getting comfortable on what you think its intrinsic value is as opposed to what the stock price suggests, Michael, two questions on that. One, can you help us how the IPO process helped you get comfortable on valuation with the obvious caveat that the IPO didn't happen? And two, maybe my guess is there's a fair amount of private market transactions going on in this space because there aren't that many publicly traded companies aside from Assurant that seem to play in some of your core businesses on the Fortegra side. So can you, is there an active private market and can you speak to where these assets trade there as sort of another foundation for what you think the intrinsic value of Fortegra might be?
spk05: Absolutely. Again, So I'll say from the IPO process, when we decided to pull, we certainly did a postmortem to say, what do we learn from this and how can we improve when we go back to the process? And in my view, it's a when, not an if. We very much believe still in the belief that Protegra would be better suited to have its own platform to have more efficient capital raises in the future for its business. When you look at valuation, it's not particularly complicated in their sector. Generally, those businesses are valued on a multiple of forward adjusted earnings. You look at last 12 months for Fortegra, and it's adjusted earnings, which are just shy of $53 million for trailing 12 months. Generally, those businesses aren't valued on a trailing, but a forward. So you can imagine our view that forward is even greater than And those multiples range, depending on where you fit with respect to the peer group that you're associated with, anywhere from 15 to 20 times. So you can start to get an idea as to where we would see value in Protegra pre-capital raise. And so on that basis, so we also did, as I said, a post-mortem to say what were self-inflicted issues that we can improve upon when we go back. And I think we've identified a number of issues. There's a little bit of complexity to the offering in the story that was told. There was a little bit of show me in the discussions with investors, particularly in the ENS business, who wanted to see some of the manifestation of the growth expectation there, which we are showing. There was also, we did a small offering. I think, frankly, there was some question of liquidity that I think we can improve upon. We did a slightly larger offering. So I think we've learned from that. We have had a lot of discussions with the bankers involved and others as to how we can improve. I'll also be frank. I think we bring a lot to the table with our investor base. I think we can do a better job of making sure bankers cover our own investor base of those who would want to participate in the Fortegra IPO. So you should expect down the road, we certainly have as a priority for us revisiting that when appropriate. Your question about private capital. There's a lot of private capital out there who certainly called us after the fact saying, what can we do with you guys? There may be some opportunities to clean up Fortegra's capital structure in a more efficient way. Certainly we'll explore that opportunistically. And there may be opportunities to enhance an IPO with the right partner, which is not an uncommon thing to see in IPOs of a private partner participating. But we'll see. Look, IPOs are hard. There's a lot of market elements that need to come together for it to work. One of the biggest issues we faced, ironically, was the market had run up so much prior to our launching the IPO that as well as having problems in the SPAC sector, which we had nothing to do with SPACs, but that had kept some of the players on the sidelines, that we found a cool market because of the run-up at the time we launched. People concerned that the market had run too far and was potentially ready for a downturn. So we had a cool reception overall, not because of Protegra or our business, but the markets in general. That didn't help. And I think these other elements we're going to improve upon. Private capital, we'll consider opportunistically when things make sense. But to your question, yeah, I actually think the capital is not only there, but frankly, somewhat aggressive in their willingness to invest at attractive levels and levels that frankly aren't too far away from where we would consider IPO capital.
spk03: So you're saying private, your guess is that private market transactions are in the space happen, transact similarly in that 50 to 20 times ballpark forward?
spk05: I don't want to put numbers on it, but I'll say there's a lot of capital being put to work right now. When that capital goes to look for investments, a well-managed, cash-flowing, growing business in the sector that Fortegra is in with a combined ratio in the low 90s with the prospects of an IPO in the relatively near term of the next let's call it a few years, I think that's a very unique investment.
spk03: Okay. And I would just chime in that the markets may not be awash with money and eager buyers forever, right? I mean, you guys are sophisticated enough to know that, but I couldn't help but chime in with that. Thank you very much for answering my questions. I appreciate it.
spk05: Absolutely, Justin. Thank you very much. Appreciate it.
spk02: Thank you. There are no more questions at this time. I would like to turn the call back to Sandra Bell for closing remarks.
spk00: Thank you, Joe. And thank you, everyone, for joining us today. This concludes our 2Q 2021 earnings call. Obviously, as always, if anyone has any additional questions, please feel free to reach out to me directly.
spk02: This concludes today's conference. You may disconnect your lines at this time. Thank you very much for your participation and have a great day.
Disclaimer